NO901728D0 - Analogifremgangsmaate for fremstilling av nye naftalenylalkyl - 3h-1,2,3,5 - oksatiadiazol-2-oksyder. - Google Patents

Analogifremgangsmaate for fremstilling av nye naftalenylalkyl - 3h-1,2,3,5 - oksatiadiazol-2-oksyder.

Info

Publication number
NO901728D0
NO901728D0 NO901728A NO901728A NO901728D0 NO 901728 D0 NO901728 D0 NO 901728D0 NO 901728 A NO901728 A NO 901728A NO 901728 A NO901728 A NO 901728A NO 901728 D0 NO901728 D0 NO 901728D0
Authority
NO
Norway
Prior art keywords
oksatiadiazol
oxyder
preparation
analogy procedure
new naphthalene
Prior art date
Application number
NO901728A
Other languages
English (en)
Other versions
NO901728L (no
Inventor
Thomas Richard Alessi
Terence Martin Dolak
John Watson Ellingboe
Louis John Lombardo
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO901728D0 publication Critical patent/NO901728D0/no
Publication of NO901728L publication Critical patent/NO901728L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO90901728A 1989-04-21 1990-04-19 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive naftalenylalkyl-3h-1,2,3,5-oksatiadiazol-2-oksyder. NO901728L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/341,340 US4897405A (en) 1989-04-21 1989-04-21 Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents

Publications (2)

Publication Number Publication Date
NO901728D0 true NO901728D0 (no) 1990-04-19
NO901728L NO901728L (no) 1990-10-22

Family

ID=23337136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90901728A NO901728L (no) 1989-04-21 1990-04-19 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive naftalenylalkyl-3h-1,2,3,5-oksatiadiazol-2-oksyder.

Country Status (12)

Country Link
US (1) US4897405A (no)
JP (1) JPH02292272A (no)
KR (1) KR900016174A (no)
CN (1) CN1046528A (no)
CA (1) CA2015032A1 (no)
DD (1) DD298925A5 (no)
FI (1) FI901956A0 (no)
HU (1) HUT54360A (no)
IL (1) IL94068A0 (no)
NO (1) NO901728L (no)
PT (1) PT93812A (no)
ZA (1) ZA903018B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4142956C2 (de) * 1991-12-24 1996-08-14 Du Pont Deutschland Bleichbares Lichthofschutzsystem für photographische Aufzeichnungsmaterialien
US6046222A (en) * 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
HU228260B1 (en) * 1993-09-15 2013-02-28 Daiichi Sankyo Company Pharmaceutical compositions to treat impaired glucose tolerance
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5399588A (en) * 1993-12-14 1995-03-21 American Home Products Corporation Naphthalenylmethyl cycloalkenone acetic acids and analogs thereof useful as aldose reductase inhibitors
US5444086A (en) * 1994-03-31 1995-08-22 American Home Products Corporation Naphthalenylmethyl thiophenones as antihyperglycemic agents
US5597826A (en) 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
US5798375A (en) * 1995-07-03 1998-08-25 Sankyo Company, Limited Treatment of arteriosclerosis and xanthoma
WO1997008126A1 (en) * 1995-08-28 1997-03-06 American Home Products Corporation Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents
AU7604596A (en) * 1995-11-17 1997-06-11 Warner-Lambert Company A method of treating myotonic dystrophy
CA2257284C (en) * 1996-05-31 2005-10-04 Sankyo Company Limited Remedy for autoimmune diseases
JP2001514663A (ja) * 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． アルツハイマー病を処置または予防するための方法
HUP9902721A2 (hu) 1997-11-25 1999-12-28 The Procter & Gamble Co. Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
CA2350599A1 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Method of inhibiting angiogenesis
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
WO2001077076A1 (fr) * 1999-06-02 2001-10-18 Torii Pharmaceutical Co., Ltd. Nouveaux derives de naphtalene
JP2001072592A (ja) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6958355B2 (en) * 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
AU2001294673A1 (en) * 2000-09-21 2002-04-02 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US20060047000A1 (en) * 2001-04-24 2006-03-02 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US20070269486A1 (en) * 2005-03-14 2007-11-22 Conor Medsystems, Llc. Methods and Devices for Reducing Tissue Damage After Ischemic Injury
CN104163864B (zh) 2007-03-30 2017-08-01 Ambrx公司 经修饰fgf‑21多肽和其用途
US20090258914A1 (en) * 2008-04-15 2009-10-15 Burnham Institute For Medical Research Inhibitor of Anti-Apoptotic Proteins
WO2012120054A1 (de) * 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2014068397A1 (en) 2012-11-05 2014-05-08 Commissariat A L'energie Atomique Et Aux Energies Atlternatives (Cea) Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a stat5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse
PL3412302T3 (pl) 2014-10-24 2021-11-02 Bristol-Myers Squibb Company Zmodyfikowane polipeptydy fgf-21 i ich zastosowania

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148801A (en) * 1978-07-03 1979-04-10 American Home Products Corporation 3-[(Chlorophenylsulfonyl)methyl]-1,2,4-oxadiazole-5-carboxylic acid derivatives
JPS5925466U (ja) * 1982-08-10 1984-02-17 安部　義雄 標準貫入試験装置
JPS59107636U (ja) * 1982-12-29 1984-07-20 ナショナル住宅産業株式会社 地耐力測定装置
JPS6095021A (ja) * 1983-10-31 1985-05-28 Natl House Ind Co Ltd 地耐力測定装置
JPH0516270Y2 (no) * 1986-03-19 1993-04-28
JPH0372937U (no) * 1989-11-16 1991-07-23

Also Published As

Publication number Publication date
NO901728L (no) 1990-10-22
KR900016174A (ko) 1990-11-12
DD298925A5 (de) 1992-03-19
IL94068A0 (en) 1991-01-31
HUT54360A (en) 1991-02-28
CA2015032A1 (en) 1990-10-21
US4897405A (en) 1990-01-30
FI901956A0 (fi) 1990-04-19
PT93812A (pt) 1990-11-20
HU902496D0 (en) 1990-08-28
CN1046528A (zh) 1990-10-31
ZA903018B (en) 1991-12-24
JPH02292272A (ja) 1990-12-03

Similar Documents

Publication Publication Date Title
NO901728D0 (no) Analogifremgangsmaate for fremstilling av nye naftalenylalkyl - 3h-1,2,3,5 - oksatiadiazol-2-oksyder.
NO880452D0 (no) Fremgangsmaate for fremstilling av nye polyaminderivater.
NO894539L (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO902776L (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO168108C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive adeninderivater
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO904372D0 (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO900074L (no) Fremgangsmaate for fremstilling av nye tetralinderivater.
NO158743C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO911118L (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO911845D0 (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive trisykliske forbindelser.
NO169590C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive sialosylglycerider
NO894038D0 (no) Fremgangsmaate for fremstilling av nye 2-karbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner.
NO845218L (no) Fremgangsmaate til fremstilling av nye 1,2-dikloretan.
NO905244L (no) Fremgangsmaate for fremstilling av des(64,65)-proinsulin.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO894037L (no) Fremgangsmaate for fremstilling av nye 2-metoksykarbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner.
NO900935D0 (no) Fremgangsmaate for fremstilling av nye piperidinderivater.
NO901401D0 (no) Fremgangsmaate for fremstilling av nye 1-difenylmethylpiperidinderivater.